The Problem
Globally, cancer is the second leading cause of human death; for dogs it is the first. Enormous research and clinical efforts have yielded some promising therapies; however, they are neither broadly effective nor affordable. Cancer has been devastating our families, our friends and our pets for too long.
45 Percent
Of all dogs living past 10 years will die of cancer.
6 Million Dogs
Are diagnosed with cancer in the US each year. The malignancy is typically very similar clinically to the human version. Each year 2 million people in the US are diagnosed.
>40 Percent
Of men and women are diagnosed with cancer at some point during their lifetime.
20 Million People
Are diagnosed with cancer worldwide each year; 10 million people die. Nearly 75% of these deaths are in low and middle-income countries.
Our Solutions
1
Diagnostic Tests
Our multi-cancer diagnostic tests detect cancers at their earliest stage (stage 1), with a small amount of blood. Existing tests do not show high sensitivity for this stage, when disease is most actionable. Our tests solve this stage 1 “sensitivity” problem.
2
Therapeutic Vaccines
Our premade therapeutic vaccines are directed at treating stage 1 cancers. They are companion products to the diagnostic tests. Since they are composed of tumor-antigens shared across patients with early disease, personal vaccine discovery and preparation is unnecessary.
3
Preventative Vaccines
Our preventative vaccines are also premade, composed of tumor-antigens shared across patients with many different cancer types. Knowing which cancer type will develop in the future is not necessary.
Be the first to know about Calviri's developments.
